MK
VRTX icon

MASTERINVEST Kapitalanlage’s Vertex Pharmaceuticals VRTX Stock Holding History

MASTERINVEST Kapitalanlage’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.7M Buy
8,293
+2,749
+50% +$1.28M 0.38% 63
2025
Q4 		$2.52M Hold
5,544
– – 0.24% 100
2025
Q3 		$2.17M Sell
5,544
-240
-4% -$100K 0.21% 111
2025
Q2 		$2.58M Buy
+5,784
New +$2.67M 0.27% 91

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

MASTERINVEST Kapitalanlage's VRTX Position: Q1 2026 in Review

MASTERINVEST Kapitalanlage increased its Vertex Pharmaceuticals (VRTX) stake by 50% in Q1 2026, buying an estimated $1.28M and bringing the position to 8,293 shares worth $3.7M. The position accounts for 0.38% of the portfolio, ranked #63.

MASTERINVEST Kapitalanlage first reported a position in VRTX in Q2 2025 and has held it in 4 quarters since. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • MASTERINVEST Kapitalanlage held 8,293 shares of Vertex Pharmaceuticals worth $3.7M as of Q1 2026.
  • MASTERINVEST Kapitalanlage bought 2,749 Vertex Pharmaceuticals shares in Q1 2026, an estimated $1.28M.
  • Vertex Pharmaceuticals made up 0.38% of MASTERINVEST Kapitalanlage's portfolio in Q1 2026, its #63 holding.
  • MASTERINVEST Kapitalanlage first reported a position in Vertex Pharmaceuticals in Q2 2025 and has held it in 4 quarters since.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on MASTERINVEST Kapitalanlage's 13F filing for Q1 2026, filed 5 May 2026.